From: Lipid profiles in French West Indies sickle cell disease cohorts, and their general population
SCA | SCC | |||||||
---|---|---|---|---|---|---|---|---|
Characteristics and lipid levels | ACS n = 9 | NoACS n = 88 | VOC n = 14 | NoVOC n = 83 | OTN n = 30 | NoOTN n = 67 | OTN n = 15 | NoOTN n = 47 |
Female sex | 4 (44.4) | 50 (56.8) | 8 (57.1) | 46 (55.4) | 19 (63.3) | 35 (52.2) | 10(66.7) | 31 (66.0) |
WHR (cm/cm) | 0.88 ± 0.02 | 0.86 ± 0.05 | 0.87 ± 0.05 | 0.86 ± 0.05 | 0.87 ± 0.05 | 0.86 ± 0.05 | 0.91 ± 0.04 | 0.84* ± 0.07 |
Hematocrit (% ± SD) | 23.6 ± 3.2 | 23.6 ± 3.7 | 25.7 ± 3.0 | 23.2* ± 3.7 | 25.25 ± 3.04 | 22.85** ± 3.69 | 30.33 ± 2.65 | 30.90 ± 2.98 |
Hemolytic Component | −0.05 ± 1.11 | 0.01 ± 0.99 | − 0.46 ± 0.68 | 0.07 ± 1.02 | − 0.35 ± 0.61 | 0.16 ** ± 1.10 | −0.07 ± 1.09 | 0.02 ± 0.98 |
TC (g/l) | 1.25 ± 0.30 | 1.21 ± 0.30 | 1.23 ± 0.26 | 1.21 ± 0.30 | 1.25 ± 0.30 | 1.20 ± 0.29 | 1.44 ± 0.32 | 1.39 ± 0.32 |
HDL-C (g/l) | 0.42 ± 0.13 | 0.36 ± 0.09 | 0.38 ± 0.09 | 0.36 ± 0.10 | 0.38 ± 0.09 | 0.36 ± 0.10 | 0.47 ± 0.14 | 0.44 ± 0.11 |
ApoA (g/l) | 1.22 ± 0.28 | 1.09 ± 0.19 | 1.15 ± 0.16 | 1.10 ± 0.21 | 1.15 ± 0.21 | 1.11 ± 0.20 | 1.32 ± 0.27 | 1.22 ± 0.16 |
Non HDL-C > 1.30 (g/l) | 1 (11.1) | 5 (5.7) | 1 (7.1) | 5 (6.0) | 3 (10.0) | 3 (4.5) | 4 (28.6) | 3 *(6.5) |
LDL-C (g/l) | 0.64 ± 0.20 | 0.66 ± 0.24 | 0.64 ± 0.21 | 0.66 ± 0.24 | 0.68 ± 0.25 | 0.64 ± 0.23 | 0.83 ± 0.23 | 0.78 ± 0.24 |
ApoB (g/l) | 0.58 ± 0.17 | 0.61 ± 0.19 | 0.57 ± 0.16 | 0.61 ± 0.19 | 0.63 ± 0.19 | 0.59 ± 0.18 | 0.69 ± 0.20 | 0.65 ± 0.19 |
TG (g/l) | 1.06 ± 0.57 | 0.96 ± 0.37 | 1.03 ± 0.53 | 0.96 ± 0.37 | 0.96 ± 0.37 | 0.97 ± 0.40 | 0.80 ± 0.49 | 0.80 ± 0.42 |
TG ≥ 1.50 g/l | 3 (33.3) | 6 *(6.9) | 3 (21.4) | 6 (7.3) | 3 (10.0) | 6 (9.1) | 1 (6.7) | 3 (6.5) |